Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prediction of coronary heart disease or heart failure using high-sensitivity cardiac troponin T: a pilot study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A totally new system is needed for drug research and development

    Research output: Contribution to journalLetterResearchpeer-review

  2. Patients not patents: Drug research and development as a public enterprise

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease

    Research output: Contribution to journalReviewResearchpeer-review

  4. Familial hypercholesterolaemia: cholesterol efflux and coronary disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Plasma suPAR is lowered by smoking cessation - a randomised controlled study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Transcriptome analysis in patients with temporal lobe epilepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Partial Oral Therapy for Osteomyelitis and Endocarditis. Reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. ProANP and proBNP in plasma as biomarkers of heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: High-sensitivity cardiac troponin T (hs-cTnT) is a good prognostic marker for mortality. However, it is uncertain if hs-cTnT can be used to detect sub-clinical cardiac disease.

METHOD: Pilot study in patients without known heart disease and elevated hs-cTnT measured at presentation to the emergency department. Hs-cTnT was measure with Roche Diagnostics. Echocardiography was used to assess structural heart disease and the participants underwent computed tomography angiography for assessment of coronary artery disease and agatston score.

RESULTS: Ten patients were included in the final cohort. Median age was 68 years IQR (57 - 78) and 80% were female (n=8). Six patients had a history of chronic obstructive lung disease and five patients had history of hypertension. The median level of hs-cTnT was 26 ng/L and values ranged from 19 ng/L - 495 ng/L. The median calcium score was 12. Three patients had signs of coronary artery disease. All patients had normal left ventricular ejection fraction with a median LVEF at 54.5%. Two patients were noted to have increased left ventricular mass index (LVMI).

CONCLUSION: The majority of patients with hs-cTnT above the 99th percentile did not have structural heart disease or ischemic coronary disease. However, 30% of the patient did have signs of coronary disease and might benefit from preventive medical treatment. Measuring hs-cTnT in absence of acute illness might be a better approach for evaluation for sub-clinical cardiac disease. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalEuropean Journal of Clinical Investigation
Volume48
Issue number10
Pages (from-to)e13009
ISSN0014-2972
DOIs
Publication statusPublished - 2018

ID: 54881791